JJs

Send your questions directly to Jim Cramer and his team of analysts at [email protected] . Reminder, we can't offer personal investing advice. We will only consider more general questions about the investment process or stocks…

Johnson & Johnson (JNJ) reported strong second - quarter profit and revenue before the opening bell Thursday, with better-than-expected results both domestically and internationally, as well as across all major operating segments. J…

Thibaut Mongon, CEO and Paul Ruh CFO of Kenvue Inc. a Johnson & Johnson's consumer-health business, pose together during the company's IPO at the New York Stock Exchange (NYSE) in New York City, U.S., May 4, 2023.Brendan McDermid |…

Johnson & Johnson products on a shelf in a store in New York.Lucas Jackson | ReutersJohnson & Johnson's consumer health business, Kenvue, is expected to go public this week in the largest U.S. IPO in more than a year. That business…

Johnson & Johnson (JNJ) before-the-bell Tuesday reported a strong first quarter, with sales up more than 5.5% and earnings eking out an annual increase. Shares of the Dow component and Club holding should not be losing 2.5% on these…

More than two years after pulling the controversial talc-based baby powder off US and Canadian shelves, Johnson & Johnson (J&J) is still supplying South African retailers with the product and has given no real date of when the…

Johnson & Johnson 's (JNJ) $16.6 billion deal to buy heart pump maker Abiomed (ABMD) will bolster its pharmaceutical and medical device business ahead of J & J's plans to separate its consumer division into a separate company. The…

The Food and Drug Administration limited the use of the Covid-19 vaccine from Johnson & Johnson after reviewing the risk of life-threatening blood clots.The agency said Thursday that the J&J shot’s…

By MATTHEW PERRONE and LAURAN NEERGAARD WASHINGTON (AP) — U.S. regulators on Thursday strictly limited who can receive Johnson & Johnson’s COVID-19 vaccine due to the ongoing risk of rare but…

By LEAH WILLINGHAM - Associated Press CHARLESTON, W.Va. (AP) — West Virginia will receive $99 million in a settlement finalized Monday with Johnson & Johnson's subsidiary Janssen Pharmaceuticals…